
The University of Chicago's venture capital strategy primarily focuses on supporting startups emerging from its own ecosystem, including those led by faculty, students, staff, and alumni. This is executed through various initiatives, such as the UChicago Startup Investment Program which co-invests with established VC firms, and Harper Court Ventures Fund I, a $25 million fund dedicated to pre-seed and seed-stage deep tech companies in areas like quantum computing, life sciences, energy, and AI. Additionally, UCM Ventures specifically targets growth-stage healthcare companies that align with UChicago Medicine's mission.
50% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Their most common stage is series-b (100% of deals).
Portfolio
2
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $27.4M | Mar 2026 | |
| Series B | $20M | Jun 2020 |
Top Co-Investors
Last updated: 5 March 2026